RESUMO
Point-of-care haemoglobin measurement devices may play an important role in the antenatal detection of anaemia in pregnant people and may be useful in guiding blood transfusion during resuscitation in obstetric haemorrhage. We compared baseline haemoglobin variability of venous and capillary HemoCue® haemoglobin, and Masimo® Rad-67 Pulse CO-Oximeter haemoglobin with laboratory haemoglobin in people on the day of their planned vaginal birth. A total of 180 people undergoing planned vaginal birth were enrolled in this prospective observational study. Laboratory haemoglobin was compared with HemoCue and Masimo Rad-67 Pulse CO-Oximeter measurements using Bland-Altman analysis, calculating mean difference (bias) and limits of agreement. Five (2.8%) people had anaemia (haemoglobin < 110 g.l-1 ). Laboratory haemoglobin and HemoCue venous haemoglobin comparison showed an acceptable bias (SD) 0.7 (7.54) g.l-1 (95%CI -0.43-1.79), with limits of agreement -14.10-15.46 g.l-1 and acceptable agreement range of 29.6 g.l-1 . Laboratory and HemoCue capillary haemoglobin comparison showed an unacceptable bias (SD) 13.3 (14.12) g.l-1 (95%CI 11.17-15.34), with limits of agreement - 14.42-40.93 g.l-1 and unacceptable agreement range of 55.3 g.l-1 . Laboratory and Masimo haemoglobin comparison showed an unacceptable bias (SD) -14.0 (11.15) g.l-1 (95%CI -15.63 to -12.34), with limits of agreement to -35.85 to 7.87 g.l-1 and acceptable agreement range of 43.7 g.l-1 . Venous HemoCue, with its acceptable bias and limits of agreement, should be applied more widely in the antenatal setting to detect, manage and risk stratify pregnant people with anaemia. HemoCue capillary measurement under-estimated haemoglobin and Masimo haemoglobin measurement over-estimated, limiting their clinical use. Serial studies are needed to determine if the accuracy of venous HemoCue haemoglobin measurement is sustained in other obstetric settings.
Assuntos
Anemia , Hemoglobinas , Humanos , Feminino , Gravidez , Hemoglobinometria/métodos , Hemoglobinas/análise , Oximetria/métodos , Anemia/diagnóstico , Testes Hematológicos , OxigênioRESUMO
Introduction: Implantation of a dual-head hip prosthesis to treat medial femoral neck fractures is often associated with significant blood loss. In elective endoprosthetics procedures, it has already been demonstrated that administration of tranexamic acid (TXA) reduces blood loss and need for postoperative transfusions, as well as reducing the frequency of postoperative complications. The aim of this study is to show whether the administration of TXA also leads to a reduction in perioperative blood loss and haemorrhage-associated complications when applied as part of treatment of femoral neck fractures using a dual-head prosthesis. Methods: In a single-centre retrospective cohort study, 1 g TXA i.v. was administered preoperatively to 93 patients who had suffered from femoral neck fractures. This group was compared to a comparison group of 65 patients who did not receive TXA (nonTXA). Outcomes were evaluated on the basis of perioperative blood loss, frequency of transfusion, and frequency of specific complications occurring. Results: The transfusion rate in the TXA group was 6% lower, whereby the volume of blood transfused was 26.7% lower than in the nonTXA group. However, neither result was significant. The calculated perioperative blood loss remained the same. Similarly, the incidence of postoperative renal failure was not significantly lower in the TXA group, at 6.5%, as compared to the nonTXA group (7.7%). A higher rate of complications or deaths as a result of TXA administration was not observed. The tranexamic acid effect seems to be related to the dose. Conclusion: Preoperative administration of TXA during implantation of a dual-head prosthesis for treatment of a femoral neck fracture does not lead to an increased complication rate. The study revealed a trend towards fewer transfusions required, but a significant reduction in blood loss could not be demonstrated. There should be further investigation of other factors influencing blood loss, in particular the dosing regimen followed for perioperative administration of TXA. Level of Evidence: Level 4: retrospective case-control study.
RESUMO
BACKGROUND: Treatment of pertrochanteric femoral fractures is often associated with significant blood loss. It has already been demonstrated that the administration of tranexamic acid (TXA) for endoprosthetic procedures reduces blood losses and leads to a decreased frequency of postoperative complications. The aim of this study is to demonstrate whether the administration of TXA as part of osteosynthesis treatment for pertrochanteric fractures using a proximal femoral nail reduces perioperative blood losses and haemorrhage-related complications. METHODS: In a two-centre retrospective cohort study, 1 g TXA i.v. was administered preoperatively to 294 patients who had suffered from pertrochanteric femoral fractures. The subjects were compared clinically to a historical control group who did not receive TXA (nonTXA). Outcomes were evaluated on the basis of perioperative blood loss, transfusion requirement, and occurrence of complications. RESULTS: The TXA group showed evidence of a reduction in blood loss (TXA = 0.97 ± 0.47 l; nonTXA = 1.06 ± 0.47 l; p = 0.004) and a lower frequency of transfusion (TXA = 20%; nonTXA = 31%; p = 0.032) as compared to the nonTXA group. However, evidence of this therapeutic effect could only be demonstrated at one of the centres on subgroup comparison between the two centres. At the second centre, the data did not show a significant difference. A trend could be seen towards a reduction in postoperative renal failure. No complications occurred resulting from the administration of tranexamic acid. CONCLUSION: Preoperative administration of TXA does not lead to an increased rate of thromboembolic complications when applied for treatment of pertrochanteric femoral fractures. Evidence of a positive effect could be seen in principle in relation to the reduction in perioperative blood loss and the frequency of transfusion. The difference in effect between the two centres remains to be clarified: for this reason, it is possible to assume that further factors influencing the efficacy of TXA administration are at play which were not taken into account in this study.
Assuntos
Antifibrinolíticos , Fraturas do Fêmur , Ácido Tranexâmico , Humanos , Estudos Retrospectivos , Perda Sanguínea Cirúrgica/prevenção & controle , Hemorragia Pós-Operatória/etiologia , Hemorragia Pós-Operatória/prevenção & controle , Fraturas do Fêmur/tratamento farmacológicoRESUMO
BACKGROUND AND AIMS: The aim of this study was to evaluate the accuracy of non-invasive haemoglobin (SpHb) compared to laboratory venous haemoglobin (tHb) measurements among patients undergoing elective transurethral resection of prostate (TURP) surgery under spinal anaesthesia. METHODS: In a prospective, observational, outcome-assessor blinded, cohort trial, we enroled 50 American Society of Anesthesiologists physical status (ASA-PS) I-II patients with benign prostatic hyperplasia. The primary outcome included SpHb and tHb measurements performed at four perioperative time-points: just before initiating the fluid preload (T1), and at 30 min (T2), 1 h (T3), and 2 h (T4) after starting the prostate resection, respectively. Statistical tool included intra-class correlation (ICC), Bland-Altman plots, and linear regression analysis. RESULTS: We collected 200 SpHb/tHb data sets from 50 patients. The SpHb had a non-significant negative bias of -0.83 g/dL, -0.43 g/dL, -0.81 g/dL, and -0.46 g/dL, with limits of agreement of 2.6 g/dL to -4.2 g/dL, 2.4 g/dL to -3.3 g/dL, 1.3 g/dL to -2.8 g/dL, and 1.4 g/dL to -2.3 g/dL, for T1 to T4, respectively. The SpHb/tHb pairs correlated significantly (time-dependent increase in ICC from T1 to T4). The SpHb-tHb difference correlated significantly with corresponding serum sodium (T1 to T3), but not with perfusion index. No correlation existed between % change in SpHb-tHb difference (T1 to T4), and intraoperative blood loss or perioperative weight gain. CONCLUSION: The SpHb exhibited a clinically acceptable negative bias compared to tHb during TURP surgery. Although a wide limit of agreement between the SpHb/tHb pairs is a limitation, the real-time SpHb trends can still serve in clinical judgement.